Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY

v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2021   193,060      
Beginning balance at Dec. 31, 2021 $ 2,091,392 $ 1,931 $ 2,743,560 $ (651,083) $ (3,016)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (15,519)     (15,519)  
Other comprehensive loss (7,339)       (7,339)
Share-based compensation 33,214   33,214    
Stock option exercises (in shares)   309      
Stock option exercises 3,190 $ 3 3,187    
Equity issuance costs (270)   (270)    
Issuance of common shares in connection with the vesting of restricted stock units (in shares)   622      
Issuances of common stock in connection with the vesting of restricted stock units 0 $ 6 (6)    
Settlement of accrued compensation liabilities through the issuance of share-based compensation awards 505   505    
Ending balance (in shares) at Sep. 30, 2022   193,991      
Ending balance at Sep. 30, 2022 2,105,173 $ 1,940 2,780,190 (666,602) (10,355)
Beginning balance (in shares) at Jun. 30, 2022   193,796      
Beginning balance at Jun. 30, 2022 2,078,657 $ 1,938 2,772,393 (691,334) (4,340)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 24,732     24,732  
Other comprehensive loss (6,015)       (6,015)
Share-based compensation 5,803   5,803    
Stock option exercises (in shares)   195      
Stock option exercises 1,996 $ 2 1,994    
Ending balance (in shares) at Sep. 30, 2022   193,991      
Ending balance at Sep. 30, 2022 $ 2,105,173 $ 1,940 2,780,190 (666,602) (10,355)
Beginning balance (in shares) at Dec. 31, 2022 194,271 194,271      
Beginning balance at Dec. 31, 2022 $ 2,124,261 $ 1,943 2,784,416 (652,876) (9,222)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 52,379     52,379  
Other comprehensive loss (303)       (303)
Share-based compensation 22,842   22,842    
Stock option exercises (in shares)   1,362      
Stock option exercises 14,898 $ 14 14,884    
Issuance of common shares in connection with the vesting of restricted stock units (in shares)   337      
Issuances of common stock in connection with the vesting of restricted stock units (110) $ 3 (113)    
Issuances of common stock in connection with the employee stock purchase plan (in shares)   123      
Issuances of common stock in connection with the employee stock purchase plan 1,450 $ 1 1,449    
Issuance of common stock in connection with a business acquisitions (in shares)   90      
Issuances of common stock in connection with business acquisitions $ 1,472 $ 1 1,471    
Ending balance (in shares) at Sep. 30, 2023 196,183 196,183      
Ending balance at Sep. 30, 2023 $ 2,216,889 $ 1,962 2,824,949 (600,497) (9,525)
Beginning balance (in shares) at Jun. 30, 2023   196,031      
Beginning balance at Jun. 30, 2023 2,200,712 $ 1,960 2,814,424 (608,412) (7,260)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 7,915     7,915  
Other comprehensive loss (2,265)       (2,265)
Share-based compensation 8,906   8,906    
Stock option exercises (in shares)   152      
Stock option exercises $ 1,621 $ 2 1,619    
Ending balance (in shares) at Sep. 30, 2023 196,183 196,183      
Ending balance at Sep. 30, 2023 $ 2,216,889 $ 1,962 $ 2,824,949 $ (600,497) $ (9,525)